InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Spragens Jeffrey G, Director. Director active across 2 companies, notably Big Cypress Acquisition Corp.. In total, 3 filings have been recorded. Split: 2 buys · 0 sell. Total volume traded: €226k. Activity tracked since 1 October 2021. The latest transaction was filed on 20 May 2022 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
299,002 shares0Common StockSEC:0001209191-22-031401:0
13,000 shares@ US$10.07100.0% of flowCommon StockSEC:0001493152-21-024641
Ideal exit: 28 Jun 2022 (T+270)
13,000 shares@ US$10.0750.0% of flowCommon StockSEC:0001493152-21-024641:0
Ideal exit: 28 Jun 2022 (T+270)
3 of 3 declarations
About Spragens Jeffrey G
Jeffrey G. Spragens is a Board Member of Big Cypress Acquisition Corp. and SAB Biotherapeutics, Inc. He brings his expertise in corporate governance and strategy, contributing to the direction and oversight of operations for these companies.
